Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2024 - 2025)

Baird Medical Investment Holdings (BDMD) recorded quarterly Non-Current Deferred Tax Liability of $21559.0 in Q2 2025, down 52.34% quarter-over-quarter from $45238.0 in Q4 2024.

Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2024 - 2025) Analysis & Trends

Baird Medical Investment Holdings' Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $21559.0 for Q2 2025.

  • In Q2 2025, Non-Current Deferred Tax Liability changed N/A year-over-year to $21559.0; the TTM figure through Jun 2025 stood at $21559.0 (changed N/A YoY), while the FY2024 annual figure was $45238.0, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability was $21559.0 for Q2 2025 at Baird Medical Investment Holdings, down from $45238.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $45238.0 in Q4 2024 to a low of $21559.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Baird Medical Investment Holdings - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 21,559.00
Jun 30, 2025 21,559.00
Dec 31, 2024 45,238.00
Dec 31, 2024 45,238.00